» Articles » PMID: 19737888

Tumor Necrosis Factor-alpha Concentrations in the Aqueous Humor of Patients with Glaucoma

Overview
Specialty Ophthalmology
Date 2009 Sep 10
PMID 19737888
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the concentration of tumor necrosis factor (TNF)-alpha in the aqueous humor of patients with glaucoma, including correlations with glaucoma subtypes and intraocular pressure.

Methods: The study population comprised 84 patients with open-angle glaucoma who were scheduled for filtration or cataract surgery. Glaucoma subgroups included 29 cases of primary open-angle glaucoma (POAG), 28 cases of normal-tension glaucoma (NTG), and 27 cases of exfoliation glaucoma (ExG). Seventy-nine patients with senile cataract were recruited as control subjects. The concentrations of TNF-alpha in the aqueous humor were measured with an enzyme-linked immunosorbent assay. The percentages of samples positive for TNF-alpha and the measured concentrations in the glaucoma and cataract groups were compared. In addition, the relationships with the glaucoma subtypes, intraocular pressure, and glaucoma severity were analyzed.

Results: A significantly higher percentage of subjects in the glaucoma group were positive for TNF-alpha compared with the cataract group (P = 0.011). The mean TNF-alpha concentrations among the positive cases were not different between the groups (P = 0.689). TNF-alpha-positive samples were higher in the POAG (13.7%) and NTG (10.7%) subgroups than in the cataract group without significance, but higher in ExG subgroup (29.6%) with significance (P = 0.001). Relationships between the TNF-alpha concentration and the intraocular pressure or the clinical stage of glaucoma were not observed.

Conclusions: TNF-alpha levels were significantly higher in the glaucoma group than in the cataract group, with a particularly large difference observed in those with ExG. The results suggest that TNF-alpha plays a key role in the progression of glaucoma.

Citing Articles

RIP1 inhibition protects retinal ganglion cells in glaucoma models of ocular injury.

Kim B, Goncharov T, Archaimbault S, Roudnicky F, Webster J, Westenskow P Cell Death Differ. 2024; 32(2):353-368.

PMID: 39448868 PMC: 11802773. DOI: 10.1038/s41418-024-01390-7.


Parallel Analysis of Exosomes and Cytokines in Aqueous Humor Samples to Evaluate Biomarkers for Glaucoma.

Shin D, Han J, Park C, Lee N, Jung K Cells. 2024; 13(12.

PMID: 38920659 PMC: 11202053. DOI: 10.3390/cells13121030.


In a novel autoimmune and high-pressure glaucoma model a complex immune response is induced.

Reinehr S, Wulf J, Theile J, Schulte K, Peters M, Fuchshofer R Front Immunol. 2024; 15:1296178.

PMID: 38515755 PMC: 10955086. DOI: 10.3389/fimmu.2024.1296178.


Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage.

Fernandez-Albarral J, Ramirez A, de Hoz R, Matamoros J, Salobrar-Garcia E, Elvira-Hurtado L Front Cell Neurosci. 2024; 18:1354569.

PMID: 38333055 PMC: 10850296. DOI: 10.3389/fncel.2024.1354569.


Differential Gene and Protein Expression of Conjunctival Bleb Hyperfibrosis in Early Failure of Glaucoma Surgery.

Milla E, Ventura-Abreu N, Vendrell C, Muniesa M, Pazos M, Gasull X Int J Mol Sci. 2023; 24(15).

PMID: 37569323 PMC: 10418990. DOI: 10.3390/ijms241511949.